电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CD226 Protein (CD226) (His tag)

This Recombinant CD226 protein is expressed in HEK-293 Cells.
产品编号 ABIN7121305
发货至: 中国

Quick Overview for CD226 Protein (CD226) (His tag) (ABIN7121305)

抗原

See all CD226 蛋白
CD226

蛋白类型

Recombinant

宿主

  • 19
  • 5
  • 2
  • 1

资源

  • 16
  • 5
  • 3
  • 2
  • 1
HEK-293 Cells

纯度

>95 % as determined by SDS-PAGE.

质量等级

SPR verified
  • 标记

    This CD226 protein is labelled with His tag.

    原理

    Canine DNAM-1 / CD226 Protein, His Tag (SPR verified)

    序列

    Glu 32 - Gln 263

    产品特性

    Canine DNAM-1, His Tag (DN1-C52H4) is expressed from human 293 cells (HEK293). It contains AA Glu 32 - Gln 263 (Accession # E2R115-1).

    内毒素水平

    Less than 1.0 EU per μg by the LAL method.
  • 想要此Protein的其他选项吗?

    !
    探索我们的预定义定制蛋白和定制蛋白服务!

    您的项目需要进一步定制吗?联系我们,了解我们的定制蛋白解决方案

  • 应用备注

    This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 28.2 kDa. The protein migrates as 36-50 kDa under reducing (R) condition due to glycosylation.

    限制

    仅限研究用
  • 状态

    Lyophilized

    缓冲液

    PBS, pH 7.4

    储存条件

    -20 °C

    储存方法

    -20°C
  • 抗原

    CD226

    别名

    DNAM-1 / CD226

    背景

    Synonyms: DNAM1,CD226,PTA1,
    Description: DNAX accessory molecule 1 (DNAM-1), a single-pass type I membrane protein, is also known as CD226 antigen and platelet and T cell activation antigen 1 (PTA1), which contains 2 Ig-like C2-type (immunoglobulin-like) domains. DNAM-1 is a ~65 kDa glycoprotein expressed on the surface of natural killer cells, platelets, monocytes and a subset of T cells. DNAM-1 mediates cellular adhesion to other cells bearing its ligands, CD112 and CD155, and cross-linking DNAM-1 with antibodies causes cellular activation. Furthermore, DNAM-1 can interact with PVR and PVRL2.

    分子量

    28.2 kDa

    途径

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
You are here:
Chat with us!